Back
Voyager Therapeutics, Inc. 10K Form
Sell
28
VYGR
Voyager Therapeutics, Inc.
Last Price:
$4.28
Seasonality Move:
-3.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VYGR News And Ratings
See the #1 stock for the next 7 days that we like better than VYGR
VYGR Financial Statistics
Sales & Book Value
| Annual Sales: | $80M |
|---|---|
| Cash Flow: | $-31.3M |
| Price / Cash Flow: | 50.49 |
| Annual Sales: | $3.96 |
| Price / Book: | 1.08 |
Profitability
| EPS (TTM): | -2.16980 |
|---|---|
| Net Income (TTM): | $-126.8M |
| Gross Margin: | $75.3M |
| Return on Equity: | -46.39% |
| Return on Assets: | -35.56% |
Voyager Therapeutics, Inc. Earnings Forecast
Key Voyager Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for VYGR is 94.09%.
-
The Selling, General & Administrative Expenses for VYGR have been equal to 44.90% of Gross Profit Margin.
-
The Research & Development expenses have been 153.29% of Revenue.
-
The Net Earning history of VYGR is -81.25% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
Voyager Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VYGR |
| CUSIP: | 92915B |
| Website: | voyagertherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 6.19 |
| Quick Ratio: | 5.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 1.34 |
|---|---|
| Forward P/E Ratio: | 0 |
VYGR Technical Analysis vs Fundamental Analysis
Sell
28
Voyager Therapeutics, Inc. (VYGR)
is a Sell
Is Voyager Therapeutics, Inc. a Buy or a Sell?
-
Voyager Therapeutics, Inc. stock is rated a SellThe current Voyager Therapeutics, Inc. [VYGR] share price is $4.28. The Score for VYGR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.